GB1261650A - 9alpha,21-DIHALOPREGNANE COMPOUNDS - Google Patents

9alpha,21-DIHALOPREGNANE COMPOUNDS

Info

Publication number
GB1261650A
GB1261650A GB29866/69A GB2986669A GB1261650A GB 1261650 A GB1261650 A GB 1261650A GB 29866/69 A GB29866/69 A GB 29866/69A GB 2986669 A GB2986669 A GB 2986669A GB 1261650 A GB1261650 A GB 1261650A
Authority
GB
United Kingdom
Prior art keywords
dihalopregnane
9alpha
compounds
compositions
june
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB29866/69A
Inventor
Joseph Elks
Gordon Hanley Phillipps
Peter John May
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Priority to GB29866/69A priority Critical patent/GB1261650A/en
Priority to BR215172/69A priority patent/BR6915172D0/en
Priority to ZA703860A priority patent/ZA703860B/en
Priority to PH11523A priority patent/PH10364A/en
Priority to IE760/70A priority patent/IE34656B1/en
Priority to IL34712A priority patent/IL34712A/en
Priority to JP45050404A priority patent/JPS4815287B1/ja
Priority to NLAANVRAGE7008655,A priority patent/NL173171C/en
Priority to DK305770AA priority patent/DK124196B/en
Priority to BE751876D priority patent/BE751876R/en
Priority to CH895470A priority patent/CH590885A5/xx
Priority to DE702029143A priority patent/DE2029143C3/en
Priority to FR7021607A priority patent/FR2052960B2/fr
Priority to ES380698A priority patent/ES380698A2/en
Publication of GB1261650A publication Critical patent/GB1261650A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

1,261,650. Antiinflammatory compositions. GLAXO LABORATORIES Ltd. 11 June, 1970 [12 June, 1969], No. 29866/69. Heading A5B. [Also in Division C2] Pharmaceutical compositions for anti-inflammatory use comprise 9α, 21-fluoro-11#- hydroxy-16-methylene-17-propionyloxypregna - 1, 4-diene-3, 20-dione and/or the corresponding 11-one and suitable carriers. They may also contain antimicrobial agents, particularly antibiotics such as neomycin. Compositions for topical and internal use are described.
GB29866/69A 1969-06-12 1969-06-12 9alpha,21-DIHALOPREGNANE COMPOUNDS Expired GB1261650A (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GB29866/69A GB1261650A (en) 1969-06-12 1969-06-12 9alpha,21-DIHALOPREGNANE COMPOUNDS
BR215172/69A BR6915172D0 (en) 1969-06-12 1969-12-15 STEROID COMPOUNDS
ZA703860A ZA703860B (en) 1969-06-12 1970-06-08 Steroid compounds
PH11523A PH10364A (en) 1969-06-12 1970-06-10 9alpha,21-dihalo-16-methyl or-methylene-17alpha-acyloxy-3,20-diketo-11-oxygenated-delta4or delta1,4-pregnanes
IE760/70A IE34656B1 (en) 1969-06-12 1970-06-11 9alpha,21-dihalopregnane compounds
IL34712A IL34712A (en) 1969-06-12 1970-06-12 9alpha,21-difluoro-16-methylene-17alpha-propionyloxy-11beta-hydroxy-pregna-1,4-diene-3,20-dione and 11-oxo derivative and anti-inflammatory compositions containing them
JP45050404A JPS4815287B1 (en) 1969-06-12 1970-06-12
NLAANVRAGE7008655,A NL173171C (en) 1969-06-12 1970-06-12 METHOD FOR PREPARING A MEDICINE AGAINST INFLAMMATIONS, FORMED MEDICINE OBTAINED THEREFOR AND METHOD FOR PREPARING COMPOUNDS SUITABLE FOR USE IN THE PREPARATION OF SUCH A MEDICINAL PRODUCT
DK305770AA DK124196B (en) 1969-06-12 1970-06-12 Analogous process for the preparation of 9α, 21-difluoro-11β-hydroxy-16-methylene-17α-propionyloxypregna-1,4-diene-3,20-dione or the corresponding 11-oxo compound.
BE751876D BE751876R (en) 1969-06-12 1970-06-12 ANTI-INFLAMMATORY STEROIDS OF THE SERIES
CH895470A CH590885A5 (en) 1969-06-12 1970-06-12
DE702029143A DE2029143C3 (en) 1969-06-12 1970-06-12 9a, 21-difIuor-16-methylen-17a-propionyloxypregna-1,4-diene compounds, processes for their preparation and pharmaceutical compositions containing them
FR7021607A FR2052960B2 (en) 1969-06-12 1970-06-12
ES380698A ES380698A2 (en) 1969-06-12 1970-07-12 9alpha,21-DIHALOPREGNANE COMPOUNDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB29866/69A GB1261650A (en) 1969-06-12 1969-06-12 9alpha,21-DIHALOPREGNANE COMPOUNDS

Publications (1)

Publication Number Publication Date
GB1261650A true GB1261650A (en) 1972-01-26

Family

ID=10298463

Family Applications (1)

Application Number Title Priority Date Filing Date
GB29866/69A Expired GB1261650A (en) 1969-06-12 1969-06-12 9alpha,21-DIHALOPREGNANE COMPOUNDS

Country Status (14)

Country Link
JP (1) JPS4815287B1 (en)
BE (1) BE751876R (en)
BR (1) BR6915172D0 (en)
CH (1) CH590885A5 (en)
DE (1) DE2029143C3 (en)
DK (1) DK124196B (en)
ES (1) ES380698A2 (en)
FR (1) FR2052960B2 (en)
GB (1) GB1261650A (en)
IE (1) IE34656B1 (en)
IL (1) IL34712A (en)
NL (1) NL173171C (en)
PH (1) PH10364A (en)
ZA (1) ZA703860B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB913942A (en) * 1958-07-31 1962-12-28 Merck & Co Inc Steroid compounds

Also Published As

Publication number Publication date
NL173171B (en) 1983-07-18
DE2029143C3 (en) 1979-03-01
IE34656L (en) 1970-12-12
ES380698A2 (en) 1975-04-01
PH10364A (en) 1977-01-18
CH590885A5 (en) 1977-08-31
JPS4815287B1 (en) 1973-05-14
IE34656B1 (en) 1975-07-09
NL7008655A (en) 1970-12-15
DE2029143B2 (en) 1978-07-06
BR6915172D0 (en) 1973-02-08
FR2052960A2 (en) 1971-04-16
DK124196B (en) 1972-09-25
ZA703860B (en) 1971-02-24
FR2052960B2 (en) 1974-05-24
NL173171C (en) 1983-12-16
IL34712A (en) 1973-11-28
BE751876R (en) 1970-12-14
DE2029143A1 (en) 1970-12-17

Similar Documents

Publication Publication Date Title
GB1253831A (en) 9alpha,21-DIHALOPREGNANE COMPOUNDS
IL45200A (en) 16 ,17 -cyclopentylidenedioxy-9 -fluoro-11 ,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate and anti-inflammatory compositions comprising it
GB1261650A (en) 9alpha,21-DIHALOPREGNANE COMPOUNDS
GB1403962A (en) Anti-inflammatory pregnane derivative
AU476623B2 (en) 3 7-hydroxy-19-nor-5d-pregnane-11, 20-dione and pharmaceutical compositions thereof
CA792234A (en) DIESTERS OF 9.alpha.,11.beta.-DIHALO-16.alpha.-ALKYL-17.alpha.,21-DIHYDROXY STEROIDS OF THE PREGNANE SERIES
CA815065A (en) N-PROPYL-13.beta. BIS NOR-18,19 SECO-4,5 PREGNANE, PREGNENE ET PREGNADIENE
ES342551A1 (en) 6alpha, 21-difluoro-9alpha, 11beta-dichloro-16alpha, 17alpha-alkylidene-dioxypregn-4-ene-3, 20 diones
CA813895A (en) 9.alpha.-CHLORO-11.beta.-HYDROXY-16.beta.-METHYL-17.alpha.,21-DIPROPIONYLOXYPREGNA 1,4-DIENE-3,20-DIONE
CA1033717A (en) 6.alpha.,7.alpha.-DIHYDRO-3'H-CYCLOPROPA(6,7)PREGNA-4,6-DIENE-3,15,20-TRIONE AND RELATED COMPOUNDS
CA766748A (en) 1,4-PREGNADIENE-17.alpha.,21-DIOL-3,11,20-TRIONE 17,21-DIACYLATE
CA880871A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 6-METHYL-16-METHYLENE-17.alpha.-HYDROXY-4,6-PREGNADIENE-3,20-DIONE 17-ACETATE
CA737447A (en) 3,6,20-TRIOXO A-NOR B-HOMO 10 .epsilon. 19-NOR PREGNANE
GB1196074A (en) 6alpha,9alpha-Difluoroprednisolone 17-Valerate 21-Acetate
CA859136A (en) 16-ALKYL-11-OXYGENATED-4-PREGNENE-17.alpha.-OL-3,20-DIONE AND THE CORRESPONDING 1,4-PREGNADIENE COMPOUNDS
CA739940A (en) 16.beta.-METHYL PREGNANE COMPOUNDS
CA690058A (en) PROCEDE DE PREPARATION DE LA 11.alpha.,17.alpha.-DIHYDROXY 16.alpha.-METHYL PREGNANE 3,20-DIONE
CA691249A (en) Procede de preparation d'un hydroxy-peroxyde de la serie du pregnane
CA740875A (en) 9-halo-4-pregnene-16,17,21-triol-3,11,20-trione and its 16,21-esters
CA715539A (en) COMPOSITIONS CONTAINING 6.alpha.-FLUORO PREDNISOLONE AND 21-ACETATE
CA731139A (en) 6.beta.-CHLORO-4-PREGNENE-17.alpha.,21-DIOL-3,20-DIONE AND ITS 21-ESTERS
CA764956A (en) 9.beta.-HALO-1- (OR 6-)-DEHYDRO-STEROIDS OF THE PREGNENE SERIES
CA717076A (en) 6.alpha.-METHYL-9.alpha.-FLUORO-11.beta.,17.alpha.-DIHYDROXY-1,4-PREGNADIENE-3,20-DIONE
CA781919A (en) 3,20 dioxo-17-methyl 19 nor pregna-4,9,11-triene
CA681993A (en) 16.beta.-METHYL-1,4-PREGNADIENE-3,20-DIONE COMPOUNDS